Protara Therapeutics
TARA
29 hedge funds and large institutions have $75.8M invested in Protara Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
9% less funds holding
Funds holding: 32 → 29 (-3)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
18% less capital invested
Capital invested by funds: $93M → $75.8M (-$17.2M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$195K |
| 2 |
DM
Deerfield Management
New York
|
+$162K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$113K |
| 4 |
SIM
Spark Investment Management
New York
|
+$101K |
| 5 |
Walleye Trading
New York
|
+$10.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$2.95M |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$234K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$206K |
| 4 |
Millennium Management
New York
|
-$124K |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$108K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $6K | – | – | – |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | +$5.63K | +16 | New |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5K | – | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $3K | +$2.81K | +8 | New |
|
|
PP
30
Paloma Partners
Greenwich,
Connecticut
| – | -$234K | -728 | Closed |
|
|
TC
31
TFS Capital
West Chester,
Pennsylvania
| – | -$206K | -642 | Closed |
|
|
32
Millennium Management
New York
| – | -$124K | -386 | Closed |
|
|
33
Baird Financial Group
Milwaukee,
Wisconsin
| – | -$108K | -336 | Closed |
|
34
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$51K | -161 | Closed |
|
35
Bank of America
Charlotte,
North Carolina
| – | -$34K | -107 | Closed |
|
TARA Hedge Fund Activity: Q3 2016 in Review
29 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2016, worth a combined $75.8M — down 18% from $93M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TARA and 4 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $195K. The largest seller was Tiverton Asset Management, cutting an estimated $2.95M.
- 29 institutional investors held Protara Therapeutics (TARA) as of Q3 2016, down from 32 in Q2 2016.
- Funds reported $75.8M of Protara Therapeutics stock for Q3 2016, down 18% quarter-over-quarter.
- 4 funds opened new Protara Therapeutics positions in Q3 2016 and 7 closed out, a net change of -3 holders.
- The largest Protara Therapeutics buyer in Q3 2016 was Bridgeway Capital Management, an estimated $195K added.
- The largest Protara Therapeutics seller in Q3 2016 was Tiverton Asset Management, an estimated $2.95M sold.
Based on aggregated 13F filings for Q3 2016.